title: [Efficacy of reamberin for the treatment of acute intestinal infections caused by opportunistic bacteria].
abstract: Reamberin was shown to improve the efficacy of the treatment of acute intestinal infections caused by opportunistic bacteria. Its introduction into combined therapy accelerated normalization of the patients' general conditions, improved their well-being, eliminated syndrome of infectious toxicosis, diarrheic and abdominal pain syndromes, decreased duration of postinfectious asthenia, had beneficial effect on biochemical and immune parameters. Reamberin reduced the level of medium-sized molecules and malonic dialdehyde to the upper normal value which suggests elimination of endogenous "metabolic" intoxication syndrome, normalization of the level of circulating immune complexes and their fractional composition. The study showed that introduction of reamberin in combined therapy of acute intestinal infections is pathogenetically justified.
authors: V M
authors: VM
authors: Frolov
authors: N A
authors: NA
authors: Peresadin
authors: Ia A
authors: IaA
authors: Sotskaia
authors: O V
authors: OV
authors: Kruglova
mesh_terms: D000208:Acute Disease; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000382:microbiology* / Q000503:physiopathology; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D008875:Middle Aged; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000382:microbiology* / Q000503:physiopathology; D013386:Succinates / Q000008:administration & dosage / Q000494:pharmacology*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: C549374:Reamberin; D013386:Succinates; D008536:Meglumine